High and variable frequencies of CYP2C19 mutations: medical consequences of poor drug metabolism in Vanuatu and other Pacific islands.
about
Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision MedicineTowards Equity in Health: Researchers Take StockClinical relevance of genetic polymorphisms in the human CYP2C subfamilyImplementing genotype-guided antithrombotic therapy.Pharmacogenetics in drug regulation: promise, potential and pitfalls.Personalized medicine: is it a pharmacogenetic mirage?Cardiovascular outcomes associated with concomitant use of clopidogrel and proton pump inhibitors in patients with acute coronary syndrome in Taiwan.The CYP2D6 polymorphism in relation to the metabolism of amitriptyline and nortriptyline in the Faroese populationClinical Application of CYP2C19 Pharmacogenetics Toward More Personalized MedicineApplication of pharmacogenomics to malaria: a holistic approach for successful chemotherapy.The osteocalcin gene rs1800247 polymorphism in Kashubian population.Effects of CYP2C19 Genetic Polymorphisms on PK/PD Responses of Omeprazole in Korean Healthy Volunteers.CYP2C19 polymorphism frequency in Russian patients in Central Russia and Siberia with acute coronary syndrome.A high incidence of polymorphic CYP2C19 variants in archival blood samples from Papua New Guinea.CYP2C19 and CYP2D6 genotypes in Pacific peoplesInclusion of diverse populations in genomic research and health services: Genomix workshop report.Genetic Polymorphism of Cytochrome p450 (2C19) Enzyme in Iranian Turkman Ethnic Group.Leveraging the Learning Health Care Model to Improve Equity in the Age of Genomic Medicine.
P2860
Q27692687-6B682E88-B9D3-408C-A072-D0E288A7881FQ28119681-24781C70-3298-4E9F-8E99-8FCF331FB48FQ28362533-6A3C0900-7381-4274-BA41-85CB696B8557Q33990428-631C8118-F374-4F98-B746-D1B58AF3FC47Q35038052-525FD2E0-DFC7-4219-9FF6-39F6EBA5CC73Q36336007-2F2B68FC-F6FB-4512-B1CF-5834D4114F73Q36390258-BC4E0703-204F-4E2E-959E-EC3763247C23Q36536020-A994EE79-4202-420C-8F6E-E1208A041DEBQ36580034-A9608FE6-58B2-477A-AD71-F9D3E1C5E177Q37278622-7BF343DF-4503-40EB-A015-D73709C1EE5EQ37321699-3EFD0D57-F41A-4203-9885-2E1A0180CB48Q37740439-2DEEF4F6-0B9F-40D8-ADBD-DEF07B747D9CQ38377522-3F26914C-620D-4E34-BDBF-F61624D2DFA6Q38423253-9DEC7871-1D55-4F14-9924-ABDE8E67B333Q38865737-02F8522A-8DF4-491D-87DE-9619AD81BB38Q42364502-F3B2E0CF-E37F-4B7F-A0D1-B98D3DE3E362Q43071574-40B958C0-2063-407B-929B-91A528F74A6AQ53452251-FC5BF25A-8FB5-4FE2-80BF-80B5B7E14125
P2860
High and variable frequencies of CYP2C19 mutations: medical consequences of poor drug metabolism in Vanuatu and other Pacific islands.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
High and variable frequencies ...... atu and other Pacific islands.
@en
High and variable frequencies ...... atu and other Pacific islands.
@nl
type
label
High and variable frequencies ...... atu and other Pacific islands.
@en
High and variable frequencies ...... atu and other Pacific islands.
@nl
prefLabel
High and variable frequencies ...... atu and other Pacific islands.
@en
High and variable frequencies ...... atu and other Pacific islands.
@nl
P2093
P1476
High and variable frequencies ...... uatu and other Pacific islands
@en
P2093
A Björkman
L Bertilsson
N Takahashi
T Ishizaki
T Kobayakawa
P304
P577
1999-10-01T00:00:00Z